FLUGEN
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.
FLUGEN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.flugen.com
Total Employee:
11+
Status:
Active
Contact:
(608) 441-2729
Email Addresses:
[email protected]
Total Funding:
71.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - FluGen
Venture Investors
Venture Investors investment in Series A - FluGen
Knox Payments
Knox Payments investment in Series A - FluGen
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation investment in Series A - FluGen
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Series A - FluGen
Knox Capital
Knox Capital investment in Venture Round - FluGen
Wisconsin Alumni Research Foundation
Wisconsin Alumni Research Foundation investment in Venture Round - FluGen
Venture Management
Venture Management investment in Venture Round - FluGen
Venture Investors
Venture Investors investment in Venture Round - FluGen
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Venture Round - FluGen
Official Site Inspections
http://www.flugen.com Semrush global rank: 5.67 M Semrush visits lastest month: 1.48 K
- Host name: flugen.supranet.net
- IP address: 66.170.16.104
- Location: Portage United States
- Latitude: 43.55
- Longitude: -89.4738
- Metro Code: 669
- Timezone: America/Chicago
- Postal: 53901
More informations about "FluGen"
FluGen - Crunchbase Company Profile & Funding
Organization. FluGen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... FluGen is a …See details»
FluGen Inc. Focused on Efficacy
FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years FluGen, Inc. 597 Science …See details»
FluGen Inc. Focused on Efficacy – Board of Directors
FluGen Company Profile | Management and Employees List
FluGen Profile and History. FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in respiratory diseases. The company's lead candidate is M2SR, a supra-seasonal, …See details»
FluGen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Flugen is a company that specializes in creating and manufacturing influenza vaccines. Flugen was established in 2007 by Yoshihiro Kawaoka, Gabriele Neumann, and Paul Radspinner and …See details»
Flugen, Inc. Company Profile | Madison, WI - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Flugen, Inc. of Madison, WI. Get the latest business insights from Dun & Bradstreet.See details»
FluGen 2025 Company Profile: Valuation, Funding
FluGen General Information Description. Operator of a clinical-stage vaccine company intended to prevent influenza and other respiratory pathogens such as COVID-19. The company's vaccines focus on the prevention of both seasonal …See details»
FluGen - Contacts, Employees, Board Members, Advisors & Alumni …
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide.See details»
FluGen Company Profile - Office Locations, Competitors, Revenue …
FluGen has 5 employees at their 1 location and $45.6 m in total funding,. See insights on FluGen including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
FLUGEN, INC. - LinkedIn
FLUGEN, INC. | 395 followers on LinkedIn. Transforming vaccine efficacy in respiratory disease. | FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in respiratory ...See details»
FluGen - Funding, Financials, Valuation & Investors - Crunchbase
FluGen is a biopharmaceutical company specializing on the prevention and treatment of seasonal and pandemic influenza worldwide. ... Experience the new Crunchbase, powered by AI . …See details»
FluGen | VentureRadar
At FluGen we’re dedicated to improving public health by developing a vaccine that can prevent disease caused by all forms of the deadly influenza virus. We are fighting a virus that mutates …See details»
FluGen - Overview, News & Similar companies | ZoomInfo.com
FluGen contact info: Phone number: (608) 441-2729 Website: www.flugen.com What does FluGen do? FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in …See details»
FluGen Inc. Focused on Efficacy – Influenza
FluGen Announces Completion of First Cohort in Age De-escalation Clinical Trial of M2SR Flu Vaccine Candidate in Pediatric Subjects Ages 6 Months to 17 Years FluGen, Inc. 597 Science …See details»
FluGen Inc. Focused on Efficacy – For Investors
To explore future investment opportunities in FluGen’s fast-tracking M2SR, contact President and CEO Paul Radspinner for more information. FluGen to Present at the 40th Annual J.P. Morgan …See details»
FluGen Inc. - WEDC
FluGen scientists are steadily advancing REDEE FLU toward our goal of developing a better, more effective influenza vaccine; one that engages the body differently and therefore provokes …See details»
FluGen - Products, Competitors, Financials, Employees, …
FluGen is a clinical-stage company focused on improving vaccine efficacy in the biotechnology sector, specifically targeting respiratory diseases. ... (HA) glycoproteins of the four influenza …See details»
Flugen, Inc. - Specialist In Influenza Vaccine Products - Medical XPRT
FluGen, Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease. The M2SR Vaccine Platform has the potential to revolutionize the $5 billion annual …See details»
FluGen Inc - Product Pipeline Analysis, 2019 Update - Research …
FluGen Inc (FluGen) is a developer of influenza vaccines and therapies. The company discovers, develops and commercializes new methods for the prevention and treatment of influenza …See details»
Leaders in Agriculture: The Sustainable Success Champions Program
17 hours ago Nutrien describes sustainable agriculture as aiming to increase farm productivity, support farmer profitability and livelihoods, and foster environmental stewardship. This …See details»